Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This is a phase 3, randomized, double-blind, placebo-controlled, parallel-design, multinational study to evaluate the efficacy and safety of tadalafil once-a-day dosing for 12 weeks in Asian men with signs and symptoms of benign prostatic hyperplasia.
Epistemonikos ID: d78348f27d265effa4898543b1a9344f92cd45b7
First added on: May 10, 2024